'Tis the Flu Season! 2020 Influenza Updates

'Tis the Flu Season! 2020 Influenza Updates Posted By:
...

On August 23, 2019, the Centers for Disease Control and Prevention published Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. While we are very much aware of the importance of annual influenza vaccination practices and keep abreast of changes, each year brings additional vaccination combinations, formulations, and dosage changes.

This year, age indications have been modified for Aflura Quadrivalent—now indicated for ≥6 months. Dose volume modifications are also recommended for Afluria Quadrivalent and Fluzone Quadrivalent in pediatric populations.

The recommendation for optimal vaccination scheduling continues to be September through October, but vaccination should be offered as long as the flu season is active. The CDC does not recommend revaccination in areas where more than one outbreak in a single community has been reported.

Antiviral treatment recommendations remain consistent from previous years and should be prescribed as early as possible for any patient with confirmed or suspected influenza who is hospitalized; has severe, complicated, or progressive illness; or is at higher risk for influenza complications. Pregnant women can be treated with oral oseltamivir; baloxavir is not recommended for treatment during pregnancy or breastfeeding.

Here are some links to this years' influenza resources:

References
  • Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2019-20 influenza season. MMWR Recomm Rep. 2019; 68:1-21.

Share

Filed under: Preventive Medicine , Public Health

Related
HIV Prevention and Testing Is Not Bound By Age

HIV Prevention and Testing Is Not Bound By Age

In 2006, the CDC updated the HIV testing guidelines to recommend routine opt-out testing for people ...

Filed under: Infectious Diseases, Preventive Medicine, Public Health, NPs & PAs


Continue Reading
A Major Change in Asthma Management – Is This the Beginning of the End for SABAs?

A Major Change in Asthma Management – Is This th ...

The most recent updated Global Initiative for Asthma (GINA) guidelines recommend that short-acting ...

Filed under: Preventive Medicine, Pulmonary Medicine, NPs & PAs, Allergy/Immunology


Continue Reading
Addressing ASCVD Risk in HIV: An Update to the DHHS HIV Guidelines

Addressing ASCVD Risk in HIV: An Update to the DHH ...

The incidence of atherosclerotic cardiovascular disease (ASCVD) is estimated to be twice as high in ...

Filed under: Infectious Diseases, Preventive Medicine, Public Health, Cardiometabolic, NPs & PAs


Continue Reading
Doxy-PEP: A New Opportunity to Reduce STIs

Doxy-PEP: A New Opportunity to Reduce STIs

According to CDC data from 2022, more than 2.5 million cases of chlamydia, gonorrhea, and syphilis w ...

Filed under: Nurses Week, Infectious Diseases, Urology, Preventive Medicine, Public Health, Substance Abuse, NPs & PAs


Continue Reading
Navigating Nonpharmacologic Approaches to Chronic Pain Management

Navigating Nonpharmacologic Approaches to Chronic ...

The concept of multimodal treatment in chronic pain management goes back to some of the early establ ...

Filed under: Psychiatry, Preventive Medicine, Public Health, Substance Abuse, NPs & PAs


Continue Reading
Tackling Disparities in HIV Prevention

Tackling Disparities in HIV Prevention

Racial and ethnic disparities have been a problem in the HIV epidemic since the very beginning. Rece ...

Filed under: Infectious Diseases, Women's Health, Preventive Medicine, Public Health, NPs & PAs


Continue Reading